NZ307958A - Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia - Google Patents

Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia

Info

Publication number
NZ307958A
NZ307958A NZ307958A NZ30795896A NZ307958A NZ 307958 A NZ307958 A NZ 307958A NZ 307958 A NZ307958 A NZ 307958A NZ 30795896 A NZ30795896 A NZ 30795896A NZ 307958 A NZ307958 A NZ 307958A
Authority
NZ
New Zealand
Prior art keywords
benzisoxazole
schizophrenia
treatment
long acting
antipsychotic agents
Prior art date
Application number
NZ307958A
Other languages
English (en)
Inventor
Mark Gabriel Palermo
Lawrence Leo Martin
Peter Allen Nemoto
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Publication of NZ307958A publication Critical patent/NZ307958A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56—Benzopyrazoles; Hydrogenated benzopyrazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NZ307958A 1995-06-06 1996-05-14 Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia NZ307958A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47040095A 1995-06-06 1995-06-06
PCT/US1996/006851 WO1996039397A1 (fr) 1995-06-06 1996-05-14 Derives de benzisoxazole et d'indazole utilises comme agents neuroleptiques

Publications (1)

Publication Number Publication Date
NZ307958A true NZ307958A (en) 1999-02-25

Family

ID=23867483

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ307958A NZ307958A (en) 1995-06-06 1996-05-14 Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia

Country Status (20)

Country Link
US (3) US5696113A (fr)
EP (1) EP0833820B1 (fr)
JP (2) JP3057763B2 (fr)
KR (1) KR100304179B1 (fr)
AR (1) AR002300A1 (fr)
AT (1) ATE199147T1 (fr)
AU (1) AU697953B2 (fr)
CA (1) CA2218663C (fr)
DE (1) DE69611783T2 (fr)
DK (1) DK0833820T3 (fr)
ES (1) ES2157442T3 (fr)
GR (1) GR3035663T3 (fr)
HU (1) HUP9802492A3 (fr)
IL (1) IL118530A0 (fr)
MX (1) MX9709451A (fr)
NO (1) NO975681L (fr)
NZ (1) NZ307958A (fr)
PT (1) PT833820E (fr)
WO (2) WO1996039397A1 (fr)
ZA (1) ZA964562B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6008348A (en) * 1995-06-06 1999-12-28 Hoechst Marion Roussel, Inc. Antipsychotic agents, compositions and method of use
TW487572B (en) * 1996-05-20 2002-05-21 Janssen Pharmaceutica Nv Aqueous suspensions of 9-hydroxyrisperidone fatty acid esters
UA72189C2 (uk) 1997-11-17 2005-02-15 Янссен Фармацевтика Н.В. Фармацевтична композиція, що містить водну суспензію субмікронних ефірів 9-гідроксирисперидон жирних кислот
US7091199B1 (en) 1999-09-14 2006-08-15 Aventis Pharmaceuticals Inc. Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists
US7125903B1 (en) * 1999-09-14 2006-10-24 Aventis Pharmaceuticals Inc. Thienoisoxazolyl-and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as D4 antagonists
US7253165B2 (en) * 1999-09-14 2007-08-07 Aventis Pharmaceuticals Inc. Benzisoxazolyl-, pyridoisoxazolyl-and benzthienyl-phenoxy derivatives useful as D4 antagonists
GB0117531D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic amide derivatives and their use as dopamine D3 receptor ligands
KR100627031B1 (ko) * 2004-09-04 2006-09-21 주식회사 케이티프리텔 등산 정보 서비스 제공 방법 및 장치
DE102005038947A1 (de) * 2005-05-18 2006-11-30 Grünenthal GmbH Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln
KR100673033B1 (ko) * 2005-06-21 2007-01-22 (주) 엘지텔레콤 레저 전용 휴대 단말기
AU2007217040A1 (en) 2006-02-17 2007-08-30 Memory Pharmaceuticals Corporation Compounds having 5-HT6 receptor affinity
CA2737252A1 (fr) * 2008-09-23 2010-04-01 F. Hoffmann-La Roche Ag Derives d'isoxazolo[4,5]pyridin-3-yl-piperazine utiles en tant que modulateurs des recepteurs de dopamine d3
TW201103904A (en) * 2009-06-11 2011-02-01 Hoffmann La Roche Janus kinase inhibitor compounds and methods
CN110117278B (zh) * 2018-02-07 2022-07-19 石家庄以岭药业股份有限公司 烷氧基苯并五元(六元)杂环胺类化合物及其药物用途

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4411901A (en) * 1981-12-23 1983-10-25 Mead Johnson & Company Benzisothiazole and benzisoxazole piperazine derivatives
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
US4806649A (en) * 1983-08-22 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3- (pyrrolidinyl)-1H-indazoles
US4853470A (en) * 1983-08-22 1989-08-01 Hoechst-Roussel Pharmaceuticals, Inc. 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
US4590196A (en) * 1984-08-23 1986-05-20 Bristol-Myers Company Analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives
MX174210B (es) * 1987-02-17 1994-04-28 Pfizer Procedimiento para la preparacion de compuestos arilpiperazinil-alquilenfenil-p-heterociclicos
EP0302423A3 (fr) * 1987-08-07 1991-01-09 Hoechst-Roussel Pharmaceuticals Incorporated Phényl-1(pipérazinyl-1)-3-indazoles-1H, procédé et intermédiares pour leur préparation, et leur utilisations comme médicaments
NZ233525A (en) * 1989-05-15 1991-09-25 Janssen Pharmaceutica Nv Piperidinyl, pyrrolidinyl and piperazinyl alkylphenol ethers and pharmaceutical compositions
EP0402644B1 (fr) * 1989-05-19 1995-08-16 Hoechst-Roussel Pharmaceuticals Incorporated N-(aryloxyalkyl)hétéroarylpipéridines et -hétéroarylpipérazines, leur procédé de préparation et leur application comme médicaments
US5364866A (en) * 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5077405A (en) * 1989-09-11 1991-12-31 Hoechst-Roussel Pharmaceuticals Incorporated 3-(1-Substituted-4-piperazinyl)-1H-indazoles
US4954503A (en) * 1989-09-11 1990-09-04 Hoechst-Roussel Pharmaceuticals, Inc. 3-(1-substituted-4-piperazinyl)-1H-indazoles
FR2671350A1 (fr) * 1991-01-08 1992-07-10 Adir Nouveaux derives de benzisoxazole et de benzisothiazole, leur procede de preparation, et les compositions pharmaceutiques les renfermant.
JP2659107B2 (ja) * 1991-03-28 1997-09-30 エーザイ株式会社 複素環式―環式アミン誘導体
US5328920A (en) * 1991-04-17 1994-07-12 Hoechst-Roussel Pharmaceuticals Incorporated Substituted (pyridinylamino)-indoles
US5177088A (en) * 1991-04-17 1993-01-05 Hoechst-Roussel Pharmaceuticals Incorporated Substituted 3-(pyridinylamino)-indoles
US5206366A (en) * 1992-08-26 1993-04-27 Pfizer Inc. Process for preparing aryl piperazinyl-heterocyclic compounds
US5494908A (en) * 1992-11-23 1996-02-27 Hoechst-Roussel Pharmaceutical Incorporated Substituted 3-(aminoalkylamino)-1,2-benzisoxazoles and related compounds

Also Published As

Publication number Publication date
NO975681D0 (no) 1997-12-05
US5696113A (en) 1997-12-09
DK0833820T3 (da) 2001-04-17
AU697953B2 (en) 1998-10-22
HUP9802492A2 (hu) 1999-09-28
AR002300A1 (es) 1998-03-11
IL118530A0 (en) 1996-10-16
CA2218663A1 (fr) 1996-12-12
NO975681L (no) 1998-02-05
ATE199147T1 (de) 2001-02-15
KR100304179B1 (ko) 2001-11-22
WO1996039405A1 (fr) 1996-12-12
EP0833820A1 (fr) 1998-04-08
DE69611783D1 (de) 2001-03-22
JPH11506728A (ja) 1999-06-15
KR19990022264A (ko) 1999-03-25
AU5746496A (en) 1996-12-24
GR3035663T3 (en) 2001-06-29
CA2218663C (fr) 2001-07-31
MX9709451A (es) 1998-02-28
ES2157442T3 (es) 2001-08-16
EP0833820B1 (fr) 2001-02-14
US5852022A (en) 1998-12-22
JP3122469B2 (ja) 2001-01-09
PT833820E (pt) 2001-07-31
HUP9802492A3 (en) 1999-10-28
JPH11507030A (ja) 1999-06-22
ZA964562B (en) 1996-12-12
US5965554A (en) 1999-10-12
DE69611783T2 (de) 2001-09-20
JP3057763B2 (ja) 2000-07-04
WO1996039397A1 (fr) 1996-12-12

Similar Documents

Publication Publication Date Title
GB9515775D0 (en) Piperidine derivatives and their use as therapeutic agents
AU6566094A (en) Heterocyclic derivatives in the treatment of ischaemia and related diseases
GB9701206D0 (en) Serine derivatives and their use as therapeutic agents
AU3391395A (en) Morpholine derivatives and their use as therapeutic agents
GB9518115D0 (en) Triazole derivatives and their use as therapeutic agents
AU7578696A (en) Morpholine derivatives and their use as therapeutic agents
AU6132496A (en) Piperidine and morpholine derivatives and their use as therapeutic agents
AU6132596A (en) Piperidine and morpholine derivatives and their use as therapeutic agents
AU3185495A (en) Spiro-substituted azacyclic derivatives and their use as therapeutic agents
IL126900A0 (en) Spiro-piperidine derivatives and their use as therapeutic agents
IL115563A (en) Substituted benzoxazoles and benzthiazoles and pharmaceutical compositions containing the same
AU5716898A (en) Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
HU9600813D0 (en) Azole derivatives and pharmaceutical composition thereof
CY2508B1 (en) Benzopyrans and their use as therapeutic agents
NZ307958A (en) Benzisoxazole and indazole derivatives as long acting antipsychotic agents and particularly in the treatment of schizophrenia
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
AU4775797A (en) Process for the determination of app secretase modulators and the use thereof as agents in the treatment of alzheimer's disease
AU3717995A (en) Mutant activated gsalpha* and adenylyl cyclase 2 for use as therapeutic agents
AU4787593A (en) Heterocyclic derivatives useful in the treatment of cardiovascular diseases
IL114228A0 (en) s-Triazinylaminostilbene derivatives and their use as optical whitening agents
ZA9811217B (en) 7-[3-[4(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl]propoxy-chromen-4-one derivatives, their preparation and their use in the treatment of psychosis, schizophrenia and allergy.
GB9621419D0 (en) 3-3-disubstituted piperidine derivatives and their use as therapeutic agents
HUP0200520A2 (hu) 2-szubsztituált 1,2-benzizotiazol-és 3-szubsztituált tetrahidro-piridopirimidinon-származékok alkalmazása agyi ischémia megelőzésére és kezelésére
PL307231A1 (en) Pyridoindolobenzodiazepines and their derivatives as antipsychotic agents
EP0714659A3 (fr) Dérivés d'indole dans le traitement de l'emesis